Responsiveness of rituximab in refractory cases of inflammatory myopathies

被引：0
|
作者：
No, J. [1 ,2 ]
Park, Y. [1 ,2 ]
机构：
[1] Pusan Natl Univ Hosp, Yangsan, South Korea
[2] Pusan Natl Univ, Yangsan Hosp, Yangsan, South Korea
来源：
NEUROMUSCULAR DISORDERS | 2023年 / 33卷
关键词：
D O I：
10.1016/j.nmd.2023.07.125
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P327
引用
收藏
页码：S96 / S96
页数：1
相关论文
共 50 条
  • [1] Rituximab treatment in patients with refractory inflammatory myopathies
    Mahler, Elien A. M.
    Blom, Marlies
    Voermans, Nicol C.
    van Engelen, Baziel G. M.
    van Riel, Piet L. C. M.
    Vonk, Madelon C.
    RHEUMATOLOGY, 2011, 50 (12) : 2206 - 2213
  • [2] Successful treatment with rituximab in patients with refractory inflammatory myopathies
    Blom, M.
    Van den Hoogen, F. H. J.
    Voermans, N. C.
    Van Riel, P. L. C. M.
    Preijers, F. W. M. B.
    Van Engelen, B. G. M.
    Barrera, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 202 - 202
  • [3] Rituximab, alternative treatment in refractory idiopathic inflammatory myopathies
    Aranda-Pereira, P.
    Melendez-Mercado, C.
    Jaimes-Hernandez, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 199 - 199
  • [4] Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
    Fernando Henrique Carlos de Souza
    Renata Miossi
    Júlio Cesar Bertacini de Moraes
    Eloisa Bonfá
    Samuel Katsuyuki Shinjo
    Advances in Rheumatology, 58
  • [5] Favorable rituximab response in patients with refractory idiopathic inflammatory myopathies
    Carlos de Souza, Fernando Henrique
    Miossi, Renata
    Bertacini de Moraes, Julio Cesar
    Bonfa, Eloisa
    Shinjo, Samuel Katsuyuki
    ADVANCES IN RHEUMATOLOGY, 2018, 58 : 31
  • [6] Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies
    Ahn, Ga Young
    Suh, Chang-Hee
    Kim, Yong-Gil
    Park, Yong-Beom
    Shim, Seung Cheol
    Lee, Sang-Heon
    Lee, Shin-Seok
    Bae, Sang-Cheol
    Yoo, Dae Hyun
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (38)
  • [7] Rituximab as an effective alternative therapy in refractory idiopathic inflammatory myopathies
    Munoz-Beamud, F.
    Isenberg, D. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (06) : 896 - 903
  • [8] Low-dose rituximab is efficacious in refractory idiopathic inflammatory myopathies
    Janardana, Ramya
    Amin, S. N.
    Rajasekhar, Liza
    Pinto, Benzeeta
    Kodishala, Chanakya
    Selvam, Sumithra
    Shobha, Vineeta
    RHEUMATOLOGY, 2023, 62 (03) : 1243 - 1247
  • [9] Rituximab in inflammatory myopathies: "A neolithic revolution"
    Hervier, B.
    Benveniste, O.
    REVUE DE MEDECINE INTERNE, 2015, 36 (08): : 505 - 508
  • [10] Rituximab for Inflammatory Myopathies in a Colombian Cohort
    Santos, Victor A.
    Aragon, Cristian C.
    Posso-Osorio, Ivan
    Naranjo-Escobar, Juan
    Milisenda, J. C.
    Obando, Maria Alejandra
    Barrera, Tatiana
    Zamorano, Laura
    Hormaza-Jaramillo, Andres
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S232 - S235
12345